Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

Covid cases rising in US as officials plan to restrict booster vaccines

Risks of a wave are compounded by new vaccine restrictions from the Trump administration

The Guardian - US · Aug 5, 2025

The world nearly beat polio. Here’s what got in the way

Fake immunisation records, an imperfect vaccine, and leadership missteps have enabled polio’s comeback, an investigation found.

Euronews · Aug 5, 2025

Vaccine plea to pregnant women as deadly virus surges

IN FULL

The Independent UK · Aug 5, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Takeaways from AP's report on problems in the worldwide campaign to eradicate polio

The World Health Organization has closed in on its bold goal of eradicating polio several times, but the paralytic virus is entrenched in parts of Afghanistan and Pakistan

The Independent UK · Aug 5, 2025

The world nearly beat polio. But fake records, an imperfect vaccine and missteps aided its comeback

The World Health Organization has closed in on its bold goal of eradicating polio several times, but the paralytic virus is entrenched in parts of Afghanistan and Pakistan

The Independent UK · Aug 5, 2025

Upholding a Vaccine Mandate, the 9th Circuit Embraces an Alarmingly Broad Definition of 'Public Health'

The appeals court held that the government may require COVID-19 shots based purely on the benefits to recipients.

Reason · Aug 4, 2025

Vaccine hesitancy: How social and technological issues converged to spawn mistrust

The rise in vaccine-preventable diseases around the world is threatening decades of progress in public health and putting millions of people at risk.

The Conversation · Aug 4, 2025

Read news from The Economist, FT, and more,
with one subscription

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

BioNTech SE (NASDAQ:BNTX) reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus loss of $2.42 per share.

Benzinga · Aug 4, 2025

Free STI vaccines now being offered across England

IN FULL

The Independent UK · Aug 4, 2025

Foot-and-mouth disease would devastate Australia’s graziers if it got in. Here’s how a new vaccine might help

It sounds innocuous. But foot-and-mouth disease is one of the world’s most economically devastating diseases affecting livestock.

The Conversation · Aug 4, 2025

World-first gonorrhoea vaccine rolled out across UK amid record levels of infection

Antibiotic-resistant strains of the infection are on the rise

The Independent UK · Aug 3, 2025

Gonorrhoea vaccine becomes available at sexual health clinics in England

The programme is targeted to those most at risk and could prevent up to 100,000 cases.

Evening Standard · Aug 3, 2025

AMA and other medical associations are kicked out of CDC vaccine workgroups

U.S. health officials have told more than a half-dozen of the nation’s top medical organizations that they will no longer help establish vaccination recommendations

The Independent UK · Aug 1, 2025

Novavax Stock Dips As Moderna's Woes Weigh On Vaccine Sector

Shares of Novavax Inc (NASDAQ:NVAX) are trading lower Friday morning, appearing to be caught in a downdraft affecting COVID-19 vaccine makers after rival Moderna Inc (NASDAQ:MRNA) reported disappointing second-quarter financial results and cut its full-year forecast.

Benzinga · Aug 1, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation · Aug 1, 2025

Shingles vaccination rates rose during the COVID-19 pandemic, but major gaps remain for underserved groups

Vaccination against shingles increased among adults age 50 and older in the U.S. during the COVID-19 pandemic, but not equally across all population groups. That’s the key finding from a new study my colleagues and I published in the journal Vaccine.

Benzinga · Aug 1, 2025

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss, an improvement from a loss of $3.33 a year ago.

Barchart · Jul 31, 2025

1 Blue-Chip Dividend Stock That Still Has Room to Run

This pharmaceutical leaders offers a combination of growth, income, and innovation.

The Independent UK · Jul 31, 2025

This rare flu complication is on the rise in otherwise healthy children

This year was one of the deadliest flu seasons for children in more than 20 years

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Jul 31, 2025

Sanofi's Q2 Earnings Fall Short On Expectations Despite 21% Jump In Dupixent Sales

Sanofi SA (NASDAQ:SNY) reported second-quarter sales of $11.33 billion (€9.99 billion euros), narrowly missing the consensus of $11.53 billion.

We Got This Covered · Jul 31, 2025

RFK Jr.’s ‘information crisis’ has doctors ditching the CDC to save your kids

Real doctors want to help you, unsurprisingly.

Benzinga · Jul 31, 2025

Moderna Announces 10% Workforce Cut Amid Declining COVID-19 Vaccine Sales, Regulatory Hurdles

Moderna Inc. (NASDAQ:MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year due to decreasing COVID-19 vaccine sales and market uncertainty.

Evening Standard · Jul 31, 2025

Parents urged to prioritise vaccine catch-ups as measles cases remain high

The latest measles data from the UK Health Security Agency shows there have been 145 cases since the last report on July 3.

Evening Standard · Jul 31, 2025

Inside the race to cure cancer: ‘We’re at the cusp of a golden era of treatment’

From new vaccines to predictive AI, Kate Wills investigates whether cancer is about to be beaten

The Independent UK · Jul 31, 2025

Vaccine researcher with green card held at San Francisco airport for a week and faces deportation

Family of Tae Heung ‘Will’ Kim, believes detention may be result of South Korean man’s decade-old marijuana misdemeanor

LiveScience · Jul 30, 2025

Experimental HIV vaccines show promise in early safety test

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

1 … 79 80 81 82

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

UK Health Security Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.